Cardiac Assist Devices (CAD) Global Market – Forecast To 2024

Published by IQ4I on 25th January 2018 | Ref: 1005273 | This Report Is In Stock

$4950 | Single User
$6750 | Site License
$9000 | Enterprise License
$4950 | Single User
$6750 | Site License
$9000 | Enterprise License

Introduction

The heart conditions are considered advanced or end stage heart failure, when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for end-stage heart failure. The availability of donor hearts is insufficient to meet the required demand and many patients are not eligible for transplantation due to age and other health conditions. The Cardiac assist devices (CAD) i.e. VAD, TAH and IABP are used to treat various conditions related to heart such as end stage heart failure, refractory angina pectoris, post-cardiopulmonary bypass shock, myocardial infarction, myocarditis, etc. The ventricular assist device is a mechanical pump that supports heart function and blood flow by taking on the workload of the left ventricle, right ventricle or both left and right ventricles helping the heart to pump oxygenated blood to the rest of the body. The indication for VAD use is acute cardiogenic shock (post cardiac surgery, myocarditis and massive myocardial infarction) and chronic heart failure. An artificial heart (TAH) is a mechanical assist device for persons with biventricular heart failure and heart transplant candidate which replaces both native ventricles and all four chambers of heart, thereby eliminating the symptoms of cardiac insufficiency or heart failure. Intra-aortic balloon pump (IABP) is placed in aorta to help the heart to pump more blood by reducing the workload on the heart and improves the function of the left ventricle as this is the chamber that pumps blood into the aorta. IABP is used in conditions such as acute mitral valve regurgitation or severe heart failure, left ventricular failure, unstable angina, etc.

According to IQ4I Analysis, CAD market is expected to grow at double digit CAGR to reach ,255.5 million by 2024. Products of Cardiac assist devices market is segmented into Ventricular Assist Device {(Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD) and Biventricular Assist Devices (Bi-VAD)}, Total Artificial Heart (TAH) and Intra-Aortic Balloon Pump (IABP). CAD market by pump type is segmented into Pulsating or Pneumatic Pump and Continuous Flow Pump. The continuous flow pump is further segmented into Axial flow pump and Centrifugal flow pump. CAD market by implant type is segmented into Extracorporeal CAD, Intracorporeal CAD and Percutaneous CAD. CAD market by patient type is segmented into Adult and Pediatric CAD. Applications of Cardiac assist devices are segmented into Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR). End-User of Cardiac assist devices are segmented into hospitals, academics & research institutes and other End-user (catheterization labs and ambulatory settings).

This report concentrates on Cardiac assist devices that are placed internally (VAD, TAH), externally (VAD) and percutaneously (VAD and IABP) for treating end-stage heart failure, cardiogenic shock, ventricular insufficiency, acute heart attack, intraoperative and postoperative cardiac procedures. The mechanical circulatory devices like extracorporeal membrane oxygenation (ECMO) or Heart lung machine and other cardiac assist devices like pacemakers and defibrillators are not considered in Cardiac assist devices global market report.

Some of the key players of the Cardiac assist devices are Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Abiomed (U.S.), Reliant Heart (U.S.), Fresenius Medical Care AG & Co. KGaA Care AG & Co. KGaA (Germany), Getinge Group (Sweden), Syncardia Systems, Inc (U.S.), Zeon Corporation (Japan), Teleflex Incorporated (U.S.), etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

• North America

o U.S.

o Others

• Europe

o Germany

o France

o U.K.

o Others

• Asia-Pacific

o Japan

o China

o India

o Others

• Rest of the World (RoW)

o Brazil

o Rest of Latin America

o Middle East and others

Table of Contents

1 EXECUTIVE SUMMARY 25

2 INTRODUCTION 30

2.1 KEY TAKEAWAYS 30

2.2 REPORT DESCRIPTION 31

2.3 MARKETS COVERED 33

2.4 STAKEHOLDERS 34

2.5 RESEARCH METHODOLOGY 35

3 MARKET ANALYSIS 44

3.1 INTRODUCTION 44

3.2 MARKET SEGMENTATION 45

3.3 FACTORS INFLUENCING MARKET 47

3.4 REGULATORY AFFAIRS 57

3.5 REIMBURSEMENT SCENARIO 65

3.6 UPCOMING TECHNOLOGY 69

3.7 CLINICL TRIAL DATA 72

3.8 PATENT TRENDS 76

3.9 TECHNOLOGICAL ADVANCEMENTS 77

3.10 PORTER’S FIVE FORCE ANALYSIS 80

3.11 SUPPLY CHAIN ANALYSIS 85

3.12 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 89

3.13 CARDIAC ASSIST DEVICES NUMBER OF UNITS BY REGION 95

3.14 COMPARISON OF CARDIAC ASSIST DEVICES 104

4 CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PRODUCT 105

4.1 INTRODUCTION 105

4.2 VENTRICULAR ASSIST DEVICES (VAD) 108

4.3 INTRA-AORTIC BALLOON PUMPS (IABP) 122

4.4 TOTAL ARTFICIAL HEART (TAH) 125

5 CARDIAC ASSIST DEVICES GLOBAL MARKET, BY IMPLANT TYPE 128

5.1 INTRODUCTION 128

5.2 EXTRACORPOREAL OR PARACORPOREAL CAD 131

5.3 INTRACORPOREAL CAD 134

5.4 PERCUTANEOUS CAD 137

6 CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PUMP TYPE 140

6.1 INTRODUCTION 140

6.2 PULSATILE FLOW PUMP 144

6.3 CONTINUOUS FLOW PUMP 147

7 CARDIAC ASSIST DEVICES GLOBAL MARKET, BY PATIENT TYPE 158

7.1 INTRODUCTION 158

7.2 PEDIATRIC CAD 161

7.3 ADULT CAD 164

8 CARDIAC ASSIST DEVICES GLOBAL MARKET, BY APPLICATION 167

8.1 INTRODUCTION 167

8.2 BRIDGE TO TRANSPLANT (BTT) 170

8.3 BRIDGE TO DESTINATION THERAPY (BTD) 173

8.4 BRIDGE TO RECOVERY (BTR) 176

9 CARDIAC ASSIST DEVICES GLOBAL MARKET, BY END-USERS 179

9.1 INTRODUCTION 179

9.2 HOSPITALS 182

9.3 ACADEMICS & RESEARCH INSTITUTES 185

9.4 OTHER END-USERS 187

10 REGIONAL ANALYSIS 190

10.1 INTRODUCTION 190

10.2 NORTH AMERICA 193

10.3 EUROPE 215

10.4 APAC 242

10.5 ROW 269

11 COMPANY DEVELOPMENTS 292

11.1 INTRODUCTION 292

11.2 APPROVALS 293

11.3 ACQUISITIONS 299

11.4 PARTNERSHIPS 302

11.5 OTHER DEVELOPMENTS 303

12 MAJOR COMPANIES 309

12.1 ABBOTT LABORATORIES 309

12.2 ABIOMED, INC. 316

12.3 BERLIN HEART GMBH 323

12.4 BIVACOR INC. 326

12.5 CARMAT SA 329

12.6 FRESENIUS MEDICAL CARE AG & CO. KGAA (XENIOS AG) 333

12.7 GETINGE GROUP (MAQUET) 338

12.8 MEDTRONIC, PLC 345

12.9 RELIANTHEART INC. 353

12.10 SYNCARDIA SYSTEMS, INC 357

12.11 TELEFLEX INCORPORATED 360

12.12 ZEON CORPORATION 367

Additional Details

Publisher

IQ4I

Publisher Information

Reference

1005273 |

Number of Pages

372

Report Format

PDF

Related Reports

Title
Date Published
Price From
Link

This report is published by IQ4I

Download Free Report Summary PDF

Cardiac Assist Devices (CAD) Global Market  – Forecast To 2024 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.